The coagulation system in patients with end-stage liver disease.

about

Coagulation parameters and major bleeding in critically ill patients with cirrhosis.Management of Coagulopathy during Bleeding and Invasive Procedures in Patients with Liver Failure

P2860

Q39813610-599E4C91-0266-4E7E-ABCA-6D1AB660E89D Q57824692-308946E4-234C-47D4-9F69-15087118CE08

P2860

The coagulation system in patients with end-stage liver disease.

Item

http://www.wikidata.org/entity/Q38295874

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

The coagulation system in patients with end-stage liver disease.

@en

type

Item

label

The coagulation system in patients with end-stage liver disease.

@en

prefLabel

The coagulation system in patients with end-stage liver disease.

@en

P1476

The coagulation system in patients with end-stage liver disease.

@en

P2093

Dominique-C Valla

http://www.w3.org/2001/XMLSchema#string

Pierre-E Rautou

http://www.w3.org/2001/XMLSchema#string

P2860

The use of desmopressin as a hemostatic agent: a concise review

Prophylactic anticoagulation for venous thromboembolism in hospitalized cirrhosis patients is not associated with high rates of gastrointestinal bleeding.

Incidence of bleeding following invasive procedures in patients with thrombocytopenia and advanced liver disease.

Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction?

Hypercoagulability in cirrhosis: causes and consequences.

Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia.

Global hemostasis tests in patients with cirrhosis before and after prophylactic platelet transfusion.

Established and new-generation antithrombotic drugs in patients with cirrhosis - possibilities and caveats.

Prophylaxis for venous thromboembolism after resection of hepatocellular carcinoma on cirrhosis: is it necessary?

Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension.

P304

139-144

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/LIV.12723

http://www.w3.org/2001/XMLSchema#string

P478

35 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P50

Pierre-Emmanuel Rautou

Dominique C Valla

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

269934873

http://www.w3.org/2001/XMLSchema#string

P698

25529099

http://www.w3.org/2001/XMLSchema#string

The coagulation system in patients with end-stage liver disease.

about

P2860

P2860

The coagulation system in patients with end-stage liver disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698